HeartFlow

Heartflow, Inc. is a medical technology company focused on improving the diagnosis and management of Coronary Artery Disease (CAD) through advanced AI and computational fluid dynamics. Founded in 2007, Heartflow has developed the Heartflow Platform, a cloud-based software that creates personalized 3D models of patients' hearts from a single Coronary Computed Tomography Angiography (CCTA) scan. This innovative approach provides clinicians with detailed insights into blood flow and plaque characteristics, enhancing diagnostic accuracy and treatment planning.

The company offers several specialized products, including Heartflow FFR~CT~ Analysis, which non-invasively calculates blood flow reserve, and Heartflow Plaque Analysis, which assesses plaque characteristics to inform risk stratification. Heartflow serves a range of customers in the healthcare sector, including hospitals, cardiology clinics, and healthcare providers, aiming to reduce unnecessary invasive procedures and improve patient outcomes. With a global presence and a commitment to innovation, Heartflow is positioned as a leader in AI-driven cardiac care.